WO2001098339A3 - Compositions et procedes de traitement et de diagnostic du cancer du sein - Google Patents
Compositions et procedes de traitement et de diagnostic du cancer du sein Download PDFInfo
- Publication number
- WO2001098339A3 WO2001098339A3 PCT/US2001/019032 US0119032W WO0198339A3 WO 2001098339 A3 WO2001098339 A3 WO 2001098339A3 US 0119032 W US0119032 W US 0119032W WO 0198339 A3 WO0198339 A3 WO 0198339A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- diagnosis
- breast cancer
- therapy
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001280443A AU2001280443A1 (en) | 2000-06-22 | 2001-06-12 | Compositions and methods for the therapy and diagnosis of breast cancer |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/602,877 US6432707B1 (en) | 1997-12-24 | 2000-06-22 | Compositions and methods for the therapy and diagnosis of breast cancer |
US09/602,877 | 2000-06-22 | ||
US68750700A | 2000-10-12 | 2000-10-12 | |
US09/687,507 | 2000-10-12 | ||
US77838101A | 2001-02-06 | 2001-02-06 | |
US09/778,381 | 2001-02-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001098339A2 WO2001098339A2 (fr) | 2001-12-27 |
WO2001098339A3 true WO2001098339A3 (fr) | 2003-07-31 |
Family
ID=27416864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/019032 WO2001098339A2 (fr) | 2000-06-22 | 2001-06-12 | Compositions et procedes de traitement et de diagnostic du cancer du sein |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001280443A1 (fr) |
WO (1) | WO2001098339A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1777201A (en) * | 1999-11-16 | 2001-05-30 | Eos Biotechnology, Inc. | Novel methods of diagnosing and determining prognosis of breast cancer, compositions, and methods of screening for breast cancer modulators |
EP2275549A1 (fr) * | 2000-06-23 | 2011-01-19 | Genentech, Inc. | Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogénèse |
CN100357320C (zh) * | 2005-01-18 | 2007-12-26 | 北京大学 | Zibc基因及其编码的蛋白和应用 |
CN100354302C (zh) * | 2005-01-18 | 2007-12-12 | 北京大学 | Sip基因及其编码的蛋白和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998018945A1 (fr) * | 1996-10-31 | 1998-05-07 | Abbott Laboratories | Reactifs et procedes pour le depistage de pathologies mammaires |
WO1998021331A1 (fr) * | 1996-11-12 | 1998-05-22 | Incyte Pharmaceuticals, Inc. | Proteines humaines specifiques de tumeur du sein |
WO1998033915A1 (fr) * | 1997-02-03 | 1998-08-06 | Human Genome Sciences, Inc. | Gene 1 specifique du cancer du sein |
WO1999033869A2 (fr) * | 1997-12-24 | 1999-07-08 | Corixa Corporation | Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation |
WO2001075171A2 (fr) * | 2000-04-03 | 2001-10-11 | Corixa Corporation | Methodes, compositions et necessaires correspondants servant au depistage et a la surveillance du cancer du sein |
-
2001
- 2001-06-12 AU AU2001280443A patent/AU2001280443A1/en not_active Abandoned
- 2001-06-12 WO PCT/US2001/019032 patent/WO2001098339A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998018945A1 (fr) * | 1996-10-31 | 1998-05-07 | Abbott Laboratories | Reactifs et procedes pour le depistage de pathologies mammaires |
WO1998021331A1 (fr) * | 1996-11-12 | 1998-05-22 | Incyte Pharmaceuticals, Inc. | Proteines humaines specifiques de tumeur du sein |
WO1998033915A1 (fr) * | 1997-02-03 | 1998-08-06 | Human Genome Sciences, Inc. | Gene 1 specifique du cancer du sein |
WO1999033869A2 (fr) * | 1997-12-24 | 1999-07-08 | Corixa Corporation | Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation |
WO2001075171A2 (fr) * | 2000-04-03 | 2001-10-11 | Corixa Corporation | Methodes, compositions et necessaires correspondants servant au depistage et a la surveillance du cancer du sein |
Non-Patent Citations (4)
Title |
---|
DIATCHENKO L ET AL: "SUPPRESSION SUBTRACTIVE HYBRIDIZATION: A METHOD FOR GENERATING DIFFERENTIALLY REGULATED OR TISSUE-SPECIFIC CDNA PROBES AND LIBRARIES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, 1 June 1996 (1996-06-01), pages 6025 - 6030, XP002911922, ISSN: 0027-8424 * |
JIANG Y ET AL: "DISCOVERY OF DIFFERENTIALLY EXPRESSED GENES IN HUMAN BREAST CANCER USING SUBTRACTED CDNA LIBRARIES AND CDNA MICROARRAYS", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 14, no. 21, 2002, pages 2270 - 2282, XP001075060, ISSN: 0950-9232 * |
MARTIN K J ET AL: "A HYBRIDIZATION ARRAY ASSAY USING DIFFERENTIAL DISPLAY-IDENTIFIED MARKERS FOR EARLY DETECTION AND STAGING OF BREAST CANCER", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 40, 10 April 1999 (1999-04-10), pages 319, XP001026342, ISSN: 0197-016X * |
XU ET AL: "Identification of differentially expressed genes in human breast tumor using substraction and microarray", CHEMICAL ABSTRACTS + INDEXES, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 40, March 1999 (1999-03-01), pages 319, XP002160220, ISSN: 0009-2258 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001098339A2 (fr) | 2001-12-27 |
AU2001280443A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001092581A8 (fr) | Compositions et methodes permettant le traitement et le diagnostic du cancer de l'ovaire | |
WO2001072295A3 (fr) | Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon | |
WO2001051633A3 (fr) | Compositions et methodes destinees au traitement et au diagnostique du cancer de la prostate | |
WO2002089747A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate | |
WO2001073032A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer de la prostate | |
WO2002060317A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du pancreas | |
WO2002074156A8 (fr) | Compositions et procedes de therapie et de diagnostic du cancer du colon | |
WO2004052276A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate | |
WO2002016413A8 (fr) | Vaccins | |
WO2002004514A3 (fr) | Compositions et procedes pour le traitement et le diagnostic du cancer du poumon | |
WO2002014503A3 (fr) | Compositions et methodes de traitement et de diagnostic de cancers associes a her-2/neu | |
WO2002092001A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer du poumon | |
WO2002074237A3 (fr) | Compositions et procedes de therapie et de diagnostic du cancer du rein | |
WO2002012328A8 (fr) | Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon | |
WO2002058534A8 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du colon | |
WO2003037267A8 (fr) | Compositions et methodes de traitement et de diagnostic du cancer des poumons | |
WO2002078516A3 (fr) | Compositions et methodes de traitement et de diagnostic de cancers | |
WO2001077168A3 (fr) | Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon | |
WO2003013431A3 (fr) | Compositions et techniques de therapie et de diagnostic du cancer du sein | |
WO2002012280A3 (fr) | Compositions et procedes pour le diagnostic et le traitement du cancer du colon | |
WO2002039885A3 (fr) | Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire | |
WO2001090152A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du sein | |
WO2005051990A3 (fr) | Compositions et procedes pour le traitement et le diagnostic du cancer du sein | |
WO2002000174A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du poumon | |
WO2003086175A3 (fr) | Compositions et procedes destines au traitement et au diagnostic du cancer du poumon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |